[Treatment of dyslipoproteinemia in patients with diabetes mellitus type 2 (non-insulin-dependent)].
Leowski
J
J
Katedry i Kliniki Chorób Wewnetrznych i Diabetologii, Warszawie.
D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000628:therapy; D003927:Diet, Diabetic; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004041:Dietary Fats / Q000008:administration & dosage; D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D006951:Hyperlipoproteinemias / Q000209:etiology / Q000628:therapy*; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D008077:Lipoproteins, LDL / Q000097:blood*; D008079:Lipoproteins, VLDL / Q000097:blood*; D008875:Middle Aged
D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004044:Dietary Proteins; D007004:Hypoglycemic Agents; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL
Leczenie dyslipoproteinemii u chorych na cukrzyce typu II (insulinoniezalezna).